EI
CLVS

Ellevest Inc’s Clovis Oncology, Inc. CLVS Stock Holding History

Ellevest Inc’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-361
Closed -$2K – 1742
2021
Q3 		$2K Buy
+361
New +$1.74K ﹤0.01% 1206
2020
Q4 		– Sell
-283
Closed -$2K – 1413
2020
Q3 		$2K Buy
283
+233
+466% +$1.39K ﹤0.01% 945
2020
Q2 		$0 Sell
50
-48
-49% -$363 ﹤0.01% 1409
2020
Q1 		$1K Buy
+98
New +$786 ﹤0.01% 1029

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ellevest Inc's CLVS Position: Q4 2021 in Review

Ellevest Inc sold out of Clovis Oncology, Inc. (CLVS) in Q4 2021, closing a stake of 361 shares — an estimated $2K sold.

Ellevest Inc first reported a position in CLVS in Q1 2020 and held it in 4 quarters. The position peaked at $2K in Q3 2021. 153 funds tracked by Wall St. Rank hold CLVS as of Q4 2021.

  • Ellevest Inc reported no remaining Clovis Oncology, Inc. position as of Q4 2021 after selling out during the quarter.
  • Ellevest Inc sold 361 Clovis Oncology, Inc. shares in Q4 2021, an estimated $2K.
  • Ellevest Inc first reported a position in Clovis Oncology, Inc. in Q1 2020 and held it in 4 quarters.
  • Ellevest Inc's Clovis Oncology, Inc. position peaked at $2K in Q3 2021.
  • 153 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2021.

Based on Ellevest Inc's 13F filing for Q4 2021, filed 24 Jan 2022.